InChI=1S/C30H36N2O3/c1- 28- 10- 8- 21- 15- 23- 26(33) 27(34) 24(32(2) 3) 16- 29(23) 11- 12- 30(21,35- 29) 25(28) 7- 6- 22(28) 19- 5- 4- 18- 9- 13- 31- 17- 20(18) 14- 19/h4- 5,8- 9,13- 15,17,22,24- 27,33- 34H,6- 7,10- 12,16H2,1- 3H3/t22- ,24+,25- ,26- ,27- ,28- ,29- ,30- /m1/s1 |
KSGZCKSNTAJOJS-DZBMUNJRSA-N |
[H][C@@]12CC[C@H](c3ccc4ccncc4c3)[C@@]1(C)CC=C1C=C3[C@@H](O)[C@H](O)[C@H](C[C@]33CC[C@]21O3)N(C)C |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via alkaloid )
|
|
angiogenesis modulating agent
An agent that modulates the physiologic angiogenesis process. This is accomplished by endogenous angiogenic proteins and a variety of other chemicals and pharmaceutical agents.
(via cortistatins )
|
|
View more via ChEBI Ontology
(1R,2R,3S,5R)- 3- (dimethylamino)- 17β- (isoquinolin- 7- yl)- 5,8α- epoxy- 9,19- cyclo- 9,10- secoandrosta- 9(11),10- diene- 1,2- diol
|
(+)-cortistatin A
|
ChEBI
|
(1R,2R,3S,5R,8α,17β)- 3- (dimethylamino)- 17- (isoquinolin- 7- yl)- 5,8- epoxy- 9,19- cyclo- 9,10- secoandrosta- 9(11),10- diene- 1,2- diol
|
IUPAC
|
10502377
|
Reaxys Registry Number
|
Reaxys
|
18479104
|
PubMed citation
|
Europe PMC
|
20925326
|
PubMed citation
|
Europe PMC
|
21539314
|
PubMed citation
|
Europe PMC
|
21651309
|
PubMed citation
|
Europe PMC
|
22879684
|
PubMed citation
|
Europe PMC
|
|